feed,title,long_url,short_url
Benzinga,FDA Approves Mirum's Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy,https://benzinga.com/analyst-ratings/analyst-color/24/03/37715746/fda-approves-mirums-livmarli-for-liver-disease-in-kids-as-young-as-5-years-analyst-,https://da.gd/XlqwC1
